Similar Articles
1521 Portal vein thrombosis and arterioportal shunts: Effects on tumor response after chemoembolization of hepatocellular carcinoma
1522 CT diagnosis of recurrence after pancreatic cancer: Is there a pattern?
1523 Body mass index is associated with age-at-onset of HCV-infected hepatocellular carcinoma patients
1524 A potential oncogenic role of the commonly observed E2F5 overexpression in hepatocellular carcinoma
1525 Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis
1526 First multicenter study for risk factors for hepatocellular carcinoma development in North Africa
1527 Hepatocellular carcinoma xenograft supports HCV replication: A mouse model for evaluating antivirals
1528 Splenic infarction associated with sorafenib use in a hepatocellular carcinoma patient
1529 Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations
1530 Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA